Literature DB >> 1334366

Age at first establishment of chronic hepatitis B virus infection and hepatocellular carcinoma risk. A birth order study.

C C Hsieh1, A Tzonou, X Zavitsanos, E Kaklamani, S J Lan, D Trichopoulos.   

Abstract

It is frequently assumed that the risk of hepatocellular carcinoma related to hepatitis B virus is higher when chronic hepatitis B virus infection is acquired early in life. This hypothesis has never been directly evaluated. However, firstborn and secondborn children are exposed to common infections after their school enrollment, whereas laterborn children are exposed much earlier, through their older siblings. The authors analyzed sibship size and birth order data from a large case-control study of patients admitted to Athens, Greece, hospitals between April 1976 and October 1984. The analyses included 185 patients with hepatocellular carcinoma, 35 patients with metastatic liver cancer, and 432 other hospital controls. There was a tendency for cases of hepatocellular carcinoma to concentrate at higher birth orders. When the analysis was restricted to cases and controls who were positive for hepatitis B surface antigen, this tendency was even more notable. These results are compatible with the hypothesis that establishment of chronic hepatitis B virus infection at an early age increases the risk of hepatocellular carcinoma substantially more than does chronic infection with this virus established at a later age.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1334366     DOI: 10.1093/oxfordjournals.aje.a116577

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  23 in total

1.  Childhood allergies, birth order and family size.

Authors:  P Cullinan
Journal:  Thorax       Date:  2006-01       Impact factor: 9.139

2.  Recognition and management of HBV infection in a social context.

Authors:  Haeok Lee; Hie-Won Hann; Jin Hyang Yang; Jacqueline Fawcett
Journal:  J Cancer Educ       Date:  2011-09       Impact factor: 2.037

3.  Complexity and uncertainty of living with an invisible virus of hepatitis B in Korea.

Authors:  Haeok Lee; Jin Hyang Yang; Myung Ok Cho; Jacqueline Fawcett
Journal:  J Cancer Educ       Date:  2010-02-26       Impact factor: 2.037

Review 4.  Update on diagnosis, management, and prevention of hepatitis B virus infection.

Authors:  F J Mahoney
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

Review 5.  Hepatitis B vaccination during pregnancy for preventing infant infection.

Authors:  Ussanee S Sangkomkamhang; Pisake Lumbiganon; Malinee Laopaiboon
Journal:  Cochrane Database Syst Rev       Date:  2014-11-11

6.  Factors associated with hepatitis B testing among Vietnamese Americans.

Authors:  Tung T Nguyen; Stephen J McPhee; Susan Stewart; Ginny Gildengorin; Lena Zhang; Ching Wong; Annette E Maxwell; Roshan Bastani; Vicky M Taylor; Moon S Chen
Journal:  J Gen Intern Med       Date:  2010-03-20       Impact factor: 5.128

7.  The size of educational differences in mortality from specific causes of death in men and women.

Authors:  Enrique Regidor; M Elisa Calle; Pedro Navarro; Vicente Domínguez
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

8.  Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma.

Authors:  V Kalapothaki; A Tzonou; C C Hsieh; N Toupadaki; A Karakatsani; D Trichopoulos
Journal:  Cancer Causes Control       Date:  1993-07       Impact factor: 2.506

Review 9.  Hepatitis B awareness, knowledge, and screening among Asian Americans.

Authors:  Tung T Nguyen; Vicky Taylor; Moon S Chen; Roshan Bastani; Annette E Maxwell; Stephen J McPhee
Journal:  J Cancer Educ       Date:  2007       Impact factor: 2.037

10.  Safety, immunization coverage and determinants of a new kind of Hepatitis B vaccine firstly applied in Ningbo, China.

Authors:  Sijia Yang; Xiao Ma; Hongxia Ni; Shaoying Zhou; Danbiao Hu; Honghui Shi; Xiaoying Chen; Hongjun Dong; Guozhang Xu
Journal:  Hum Vaccin Immunother       Date:  2015-07-25       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.